In announcements concerning the Russian coronavirus vaccine Sputnik-V The Russian Direct Investment Fund (RDIF) made on Friday (9/7) emphasizing that the interval between the first and the second installment can reach 180 days.
RDIF, citing the institute that developed the vaccine, stressed that the longer the interval between doses ensures a better immune response.
The Food and Drug Administration of the Philippines announced this week that the Gamale Institute in Moscow had requested that the interval between two doses be increased to 90 from the current 21 days.
RDIF, which commercially promotes Russian vaccine told Reuters that the longer interval between two doses ensures a better immune response and has nothing to do with overseas sales of the vaccine.
“Prolongation of the allowable interval between the first and second dose of Sputnik-V vaccine is not related to international sales”, said the representative of RDIF as broadcast by the Athens News Agency, answering the question whether the countries to which the Russian vaccine is sold, decide to extend the period due to delays in the supply of the vaccine.
Earlier, Alexander Ginsburg, director of the Gamaley Scientific Research Center in Moscow, said that the interval between doses of the vaccine could be increased from 21 to 90 days. Some countries, for example Kazakhstan, Argentina, the Philippines “increased the interval between doses of the Sputnik-V vaccine, while in Russia this interval remains at 21 days.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
